Metformin can inhibit phenylephrine-induced cardiomyocyte hypertrophy by inhibiting p300 in cultured cardiomyocytes; therefore, it can potentially be used for the treatment of patients with diabetes and HF (52). This evidence concerns the gene EP300 and hydrops fetalis.